Skip to main content

Table 1 Laboratory and oocyte-dependent characteristics before and after treatment with platelet-rich plasma (PRP) in the whole population

From: Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria

Variables

Before PRP (Median ± IQR)

After PRP (Median ± IQR)

P-value

LH

2.80 ± 1.93

2.88 ± 1.76

0.962

FSH

6.21 ± 4.48

6.41 ± 3.72

0.059

Estradiol

51.00 ± 34.10

50.00 ± 32.68

0.771

AMH

0.72 ± 0.87

0.73 ± 1.04

0.905

Total ovocyte number

2.00 ± 3.00

3.00 ± 6.00

 < 0.001

GV ovocyte number

0.00 ± 0.00

0.00 ± 0.00

0.604

MI ovocyte number

0.00 ± 0.00

0.00 ± 0.00

0.210

MII ovocyte number

1.00 ± 3.00

3.00 ± 5.00

 < 0.001

  1. LH Luteinizing hormone, FSH Follicle-stimulating hormone, AMH Anti-Mullerian hormone
  2. P-values have been calculated by Wilcoxon rank test